Well, PSDV will not receive 66 MIL, they'll get 25 MIL. upon approval. They will however, as you mentioned, profit share 20%. If you're correct about the sales potential of the drug(500 MIL/year) then the stock price should increase 5 fold, and have a market cap of 500 million. It may take a couple of years to build the Illuvien sales but you're not missing anything. If they don't get approval, for whatever reason, the stock will tank and they'll have to dilute to raise capital. I'm a bull.